FDA advisory panelist outlines issues with aducanumab's approval for Alzheimer's disease
by American College of PhysiciansPET scan of a human brain with Alzheimer's disease. Credit: public domainDespite near unanimous objection from its advisory panel, the U.S. Food and Drug Admi
Updated on: March 30,2024
10
FDA advisory panelist outlines issues with aducanumab's approval for Alzheimer's disease
by American College of PhysiciansPET scan of a human brain with Alzheimer's disease. Credit: public domainDespite near unanimous objection from its advisory panel, the U.S. Food and Drug Admi
Updated on:March 30,2024
10